For decades, glioblastoma has been one of the most feared diagnoses in medicine. The aggressive brain cancer spreads like invisible threads through healthy brain tissue, making complete removal nearly impossible. Traditional treatments—surgery, radiation, and chemotherapy—often slow the disease only temporarily. But a stunning moment in 2024 has shaken the field of cancer research. Scientists at Mass General Brigham launched a groundbreaking clinical trial using an advanced form of immunotherapy known as CAR-T cell therapy. Instead of drugs attacking the tumor, doctors re-engineered the patient’s own immune cells in a laboratory, turning them into highly targeted cancer hunters designed to recognize... Continues…





